Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial User montaukwhaler, in the non small cell lung cancer subreddit, 17 Mar 2017